Rhinitus/Sinusitis/Ocular Allergy News

A new feature within the SONU app called SONUCheck allows individuals to check the openness of their nasal passages/congestion in real-time with a voice recording, according to a press release from SoundHealth Inc.

The FDA has proposed an order for the removal of oral phenylephrine as an active ingredient from over-the-counter monograph drug products for relieving nasal congestion, according to an administration press release.

Healio has compiled October’s most read news in asthma and allergy.

BOSTON — Poor allergic rhinitis control was associated with an increase of depressive and anxiety symptoms, according to a poster presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Children with atopic disease had increased risks for developing eosinophilic esophagitis, according to an abstract presented at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

BOSTON — Patients aged 65 years and older on dupilumab for asthma and chronic rhinosinusitis experienced greater risks for adverse events than younger patients, according to a poster presented at the CHEST Annual Meeting.

Healio has compiled September’s most-read news in asthma and allergy.

Regeneron Pharmaceuticals Inc. and Sanofi announced the FDA approval of dupilumab for adolescents aged 12 to 17 years with chronic rhinosinusitis with nasal polyps.

Sublingual immunotherapy for house dust mite allergy improved allergic rhinitis symptoms among children aged 1 to 4 years over 12 months, according to a study published in Pediatric Allergy and Immunology.